Enrico Gandolfo
Overview
Explore the profile of Enrico Gandolfo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
206
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mistraletti G, Gristina G, Mascarin S, Iacobone E, Giubbilo I, Bonfanti S, et al.
BMJ Support Palliat Care
. 2020 Oct;
14(e3):e2954-e2965.
PMID: 33060189
Importance: During the SARS-CoV-2 pandemic, a complete physical isolation has been worldwide introduced. The impossibility of visiting their loved ones during the hospital stay causes additional distress for families: in...
2.
Vergano M, Naretto G, Elia F, Gandolfo E, Calliera C, Gristina G
Crit Care
. 2019 Jun;
23(1):204.
PMID: 31171017
No abstract available.
3.
Wild J, Chiron C, Ahn H, Baulac M, Bursztyn J, Gandolfo E, et al.
CNS Drugs
. 2009 Oct;
23(11):965-82.
PMID: 19845417
Background: Use of the antiepileptic drug vigabatrin is associated with an elevated risk of visual field loss. Objective: To determine the frequency of, and risk factors for, vigabatrin-attributed visual field...
4.
Wild J, Ahn H, Baulac M, Bursztyn J, Chiron C, Gandolfo E, et al.
Epilepsia
. 2007 Jul;
48(7):1318-27.
PMID: 17635558
Purpose: The risk factors for visual field loss attributable to vigabatrin (VAVFL) are equivocal. This multinational, prospective, observational study aimed to clarify the principal/major factors for VAVFL. Methods: Interim analysis...
5.
Quaranta L, Gandolfo F, Turano R, Rovida F, Pizzolante T, Musig A, et al.
Invest Ophthalmol Vis Sci
. 2006 Jun;
47(7):2917-23.
PMID: 16799034
Purpose: To compare the short-term effects of timolol 0.5%, brimonidine 0.2%, dorzolamide 2%, and latanoprost 0.005% on intraocular pressure (IOP), blood pressure (BP), and diastolic ocular perfusion pressure (DOPP), calculated...
6.
Rizzo S, Genovesi-Ebert F, Belting C, Foltran F, Gandolfo E, Lesnoni G, et al.
Ophthalmologica
. 2005 Jun;
219(3):147-53.
PMID: 15947500
Aim: To report on the use of a combined intra-ocular tamponade with silicone oil and perfluorohexyloctane (F(6)H(8)) in the treatment of complex retinal detachment. Design: A prospective consecutive interventional case...
7.
Bruno G, Cerutti F, Merletti F, Cavallo-Perin P, Gandolfo E, Rivetti M, et al.
Diabetes Care
. 2005 Jan;
28(2):312-7.
PMID: 15677785
Objective: The hypothesis of age-dependent variations in epidemiologic and clinical features at onset of type 1 diabetes has been assessed in the registry of the province of Turin, Italy. Research...
8.
Viola F, Morescalchi F, Gandolfo E, Staurenghi G
Arch Ophthalmol
. 2004 Oct;
122(10):1549-51.
PMID: 15477474
No abstract available.
9.
Quaranta L, Semeraro F, Turano R, Gandolfo E
J Glaucoma
. 2004 Apr;
13(2):90-5.
PMID: 15097252
Purpose: Based on the known neurocristopathic etiology of type 1 neurofibromatosis (NF1) and the neuroectodermal embryologic derivation of the iridocorneal angle, we examined a sample of young patients affected with...
10.
Quaranta L, Bettelli S, Uva M, Semeraro F, Turano R, Gandolfo E
Ophthalmology
. 2003 Feb;
110(2):359-62; discussion 362-4.
PMID: 12578781
Objective: To evaluate the effect of Ginkgo biloba extract (GBE) on preexisting visual field damage in patients with normal tension glaucoma (NTG). Design: Prospective, randomized, placebo-controlled, double-masked cross-over trial. Participants:...